Brawn Biotech Limited
Brawn Biotech Limited is a Public Non-govt company company incorporated in 1985 and based in Delhi, India. Brawn Biotech Limited operates in Business Services (NIC 74899) with authorized capital of ₹4.50 Cr and paid-up capital of ₹3.00 Cr. For 2023-24, the company reported revenue of ₹16.49 Cr and a net loss of ₹1.25 Cr. RegisterKaro's Compliance Health Score for the company is 35/100 (grade F), reflecting a weak compliance posture.
BRAWN BIOTECH LIMITED is the legal entity of Brawn Biotech and Brawnpharma.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Brawn Biotech Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +3d | filed |
| MGT-7 | FY2024-25 | 27 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +22d | filed |
| MGT-7 | FY2023-24 | 27 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 25 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Brawn Biotech Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 726054133 | State Bank of India(Bank) | ₹1.28 Cr | 19 Sep 2023 | Satisfied |
| 131279363 | State Bank of India(Bank) | ₹5.33 Cr | 12 Mar 2023 | Satisfied |
| 707644285 | Axis Bank Ltd(Bank) | ₹8.68 Cr | 12 Mar 2019 | Open |
| 516862808 | Kotak Mahindra Bank Ltd(Bank) | ₹3.30 Cr | 27 Jan 2023 | Satisfied |
| 872969862 | HDFC Bank Ltd(Bank) | ₹1.76 Cr | 12 Mar 2021 | Satisfied |
Charge IDs, lenders & amounts for Brawn Biotech Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2023-24 | — | ||||
| 2022-23 | — | ||||
| 2021-22 | — | ||||
| 2020-21 | — | ||||
| 2018-19 | — | ||||
| 2017-18 | — | ||||
| 2016-17 | — |
Detailed Financials
4 FYs| Line item | 2023-24 | 2022-23 | 2021-22 | 2020-21 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ||||
| Other income | ||||
| Total income | ||||
| Total expenses | ||||
| Profit before tax | ||||
| Profit / (Loss) after tax | ||||
| Balance sheet | ||||
| Equity / Net worth | ||||
| Borrowings | ||||
| Current liabilities | ||||
| Total liabilities | ||||
| Current assets | ||||
| Cash & equivalents | ||||
| Total assets | ||||
| Employees | — | — | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2023-24 | -11.0% | -37.0% | -95.0% | |
| Profit after Tax2023-24 | — | — | — | |
| Net Worth2023-24 | -88.0% | -79.0% | -3.0% |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2016-17 | +2.28% | — | +21.84% | +8.18% | — | |||
| 2017-18 | +0.00% | -8.80% | +0.00% | +0.00% | 1.96 | |||
| 2018-19 | +2.04% | +16.84% | +15.40% | +5.92% | 1.60 | |||
| 2020-21 | -1.57% | -46.34% | -6.26% | -3.97% | 0.58 | |||
| 2021-22 | -19.08% | -75.35% | -22.77% | -11.93% | 0.91 | |||
| 2022-23 | -3.91% | +157.88% | -13.76% | -5.97% | 1.30 | |||
| 2023-24 | -7.56% | -25.80% | -24.62% | -8.55% | 1.88 |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 1 | 1,77,11,971 | 85.70% |
| Institutional Investors | 3 | 4,66,716 | 2.26% |
| Public & Others | 58 | 24,89,422 | 12.04% |
Promoter, institutional & public holding for Brawn Biotech Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
264 peersEvents & timeline
2External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.